Authors' response to "Evaluation of Treatments for HIV-Associated Kaposi Sarcoma in Africa".

Coldiron ME Gutierrez Zamudio AG Manuel R Ciglenecki I Trellu LT Molfino L
Infectious agents and cancer 2021 May 05; 16(1); 27. doi: 10.1186/s13027-021-00372-5. Epub 2021 05 05
AIDS-related opportunistic infections Acquired Immunodeficiency Syndrome Doxorubicin Kaposi sarcoma Mozambique